These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29214581)

  • 1. Newborn Screening: Beyond the Spot.
    Urv TK; Parisi MA
    Adv Exp Med Biol; 2017; 1031():323-346. PubMed ID: 29214581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2012 Apr; 61(RR-2):1-44. PubMed ID: 22475884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating Newborn Screening in the NICU: A User's Guide.
    Kronn D
    Neoreviews; 2019 May; 20(5):e280-e291. PubMed ID: 31261080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Historical and Current Review of Newborn Screening for Neuromuscular Disorders From Around the World: Lessons for the United States.
    Ross LF; Clarke AJ
    Pediatr Neurol; 2017 Dec; 77():12-22. PubMed ID: 29079012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded newborn screening: social and ethical issues.
    Dhondt JL
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S211-7. PubMed ID: 20544288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACOG Committee Opinion No. 778 Summary: Newborn Screening and the Role of the Obstetrician-Gynecologist.
    Obstet Gynecol; 2019 May; 133(5):1073-1074. PubMed ID: 31022120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening: an overview.
    Carreiro-Lewandowski E
    Clin Lab Sci; 2002; 15(4):229-38. PubMed ID: 12776783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACOG Committee Opinion No. 778: Newborn Screening and the Role of the Obstetrician-Gynecologist.
    Obstet Gynecol; 2019 May; 133(5):e357-e361. PubMed ID: 31022124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening and the recommended uniform screening panel: Optimal submissions and suggested improvements based on an advocacy organization's decade-long experience.
    Ellinwood NM
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):156-161. PubMed ID: 36135708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State Legislation, Regulations, and Hospital Guidelines for Newborn Screening for Critical Congenital Heart Defects - United States, 2011-2014.
    Glidewell J; Olney RS; Hinton C; Pawelski J; Sontag M; Wood T; Kucik JE; Daskalov R; Hudson J;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):625-30. PubMed ID: 26086632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of expanded newborn screening--United States, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(37):1012-5. PubMed ID: 18802410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Harms in the Assessment of Net Benefit: A Framework for Newborn Screening Condition Review.
    Goldenberg AJ; Comeau AM; Grosse SD; Tanksley S; Prosser LA; Ojodu J; Botkin JR; Kemper AR; Green NS
    Matern Child Health J; 2016 Mar; 20(3):693-700. PubMed ID: 26833040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A framework for assessing outcomes from newborn screening: on the road to measuring its promise.
    Hinton CF; Homer CJ; Thompson AA; Williams A; Hassell KL; Feuchtbaum L; Berry SA; Comeau AM; Therrell BL; Brower A; Harris KB; Brown C; Monaco J; Ostrander RJ; Zuckerman AE; Kaye C; Dougherty D; Greene C; Green NS;
    Mol Genet Metab; 2016 Aug; 118(4):221-9. PubMed ID: 27268406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Current State of Newborn Screening in the United States.
    Fabie NAV; Pappas KB; Feldman GL
    Pediatr Clin North Am; 2019 Apr; 66(2):369-386. PubMed ID: 30819343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children.
    Kemper AR; Green NS; Calonge N; Lam WK; Comeau AM; Goldenberg AJ; Ojodu J; Prosser LA; Tanksley S; Bocchini JA
    Genet Med; 2014 Feb; 16(2):183-7. PubMed ID: 23907646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening research sponsored by the NIH: From diagnostic paradigms to precision therapeutics.
    Minear MA; Phillips MN; Kau A; Parisi MA
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):138-152. PubMed ID: 36102292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDC Grand Rounds: Newborn Screening for Hearing Loss and Critical Congenital Heart Disease.
    Grosse SD; Riehle-Colarusso T; Gaffney M; Mason CA; Shapira SK; Sontag MK; Braun KVN; Iskander J
    MMWR Morb Mortal Wkly Rep; 2017 Aug; 66(33):888-890. PubMed ID: 28837548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Committee Report: advancing the current recommended panel of conditions for newborn screening.
    Green NS; Rinaldo P; Brower A; Boyle C; Dougherty D; Lloyd-Puryear M; Mann MY; Howell RR;
    Genet Med; 2007 Nov; 9(11):792-6. PubMed ID: 18007148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging Evidence-Based Public Policy and Advocacy to Advance Newborn Screening in California.
    Bronstein MG; Pan RJ; Dant M; Lubin B
    Pediatrics; 2019 Feb; 143(2):. PubMed ID: 30606745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.